Prognostic Value of Germline DNA Repair Gene Mutations in De Novo Metastatic and Castration-Sensitive Prostate Cancer

Oncologist - United States
doi 10.1634/theoncologist.2019-0495
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Inherited DNA Repair Gene Mutations in Men With Lethal Prostate Cancer

Genes
Genetics
2020English

Clinical Outcome of Prostate Cancer Patients With Germline DNA Repair Mutations: Retrospective Analysis From an International Study

European Urology
Urology
2018English

Toward Understanding De Novo Germline Mutations in Mammals

Genes and Genetic Systems
MedicineGeneticsMolecular Biology
2019English

Castration Radiosensitizes Prostate Cancer Tissue by Impairing DNA Double-Strand Break Repair

Science Translational Medicine
Medicine
2015English

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

The Addition of Apalutamide to ADT in the Treatment of Metastatic Castration-Sensitive Prostate Cancer: Safety and Efficacy

Expert Review of Anticancer Therapy
OncologyPharmacology
2020English

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Clinical Medicine Insights: Oncology
Oncology
2013English

Branched Chain RNA in Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2016English

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy